Search Results

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

• Authors : Ray-Coquard, Isabelle; Pautier, Patricia; Pignata, Sandro

• Source: The New England Journal of Medicine. Dec 19, 2019, Vol. 381 Issue 25, p2416, 13 p.

Record details

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

• Authors : Gonzalez-Martin, Antonio; Pothuri, Bhavana; Vergote, Ignace

• Source: The New England Journal of Medicine. Dec 19, 2019, Vol. 381 Issue 25, p2391, 12 p.

Record details

Management of advanced ovarian cancer in Spain: an expert Delphi consensus

• Authors : Redondo, Andres; Oaknin, Ana; Rubio, Maria Jesus

• Source: Journal of Ovarian Research. May 26, 2021, Vol. 14 Issue 1

Record details

Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma.

• Authors : Christinat, Yann; Ho, Liza; Clément, Sophie

Subjects: POLY ADP ribose; CLINICAL trials; OLAPARIBGENEVA (Switzerland)

• Source: JCO Precision Oncology; 6/26/2023, Vol. 7, p1-9, 9p

Record details

EPIK-O/ENGOT-OV61: alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study).

• Authors : Konstantinopoulos, Panagiotis A; Gonzalez-Martin, Antonio; Cruz, Felipe Melo

• Source: Future Oncology; Oct2022, Vol. 18 Issue 31, p3481-3492, 12p

Record details

Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.

• Authors : Callens, Céline; Vaur, Dominique; Soubeyran, Isabelle

Subjects: BRCA genes; OVARIAN cancer; GERM cells

• Source: JNCI: Journal of the National Cancer Institute; Jul2021, Vol. 113 Issue 7, p917-923, 7p

Record details

The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes.

• Authors : Salas-Benito, Diego; Conde, Enrique; Tamayo-Uria, Ibon

• Source: British Journal of Cancer; Mar2021, Vol. 124 Issue 6, p1138-1149, 12p

Record details

GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles

• Authors : Pozzorini, Christian; Andre, Gregoire; Coletta, Tommaso

• Source: Cell Reports Medicine; December 2023, Vol. 4 Issue: 12

Record details

Results of the interprofessional and interdisciplinary Berlin round table on patient-reported outcomes, quality of life, and treatment expectations of patients with gynecological cancer under maintenance treatment.

• Authors : Armbrust, Robert; Alavi, Sara; Pirmorady, Adak

• Source: International Journal of Gynecological Cancer; Oct2020, Vol. 30 Issue 10, p1603-1607, 5p

Record details

Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey.

• Authors : Greggi, Stefano; Falcone, Francesca; Scaffa, Cono

• Source: International Journal of Gynecological Cancer; Jun2020, Vol. 30 Issue 6, p819-824, 6p

Record details